SCHEMBL16795384

SCHEMBL16795384

CN1CCC(NCc2ccc(B(O)O)cc2O)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 6/20 0.47
ACHE P22303 6/20 0.47
BACE1 P56817 6/20 0.47
PABPC1 P11940 1/20 0.43
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HTT P42858 1/20 0.39
CARM1 Q86X55 1/20 0.37
PRMT6 Q96LA8 1/20 0.37
SLC2A1 P11166 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
QDPR P09417 1/20 0.35
ADRB2 P07550 2/20 0.35
ADRB1 P08588 2/20 0.35
ADRB3 P13945 2/20 0.35
CXCR3 P49682 1/20 0.35
MAPK14 Q16539 2/20 0.35
DRD2 P14416 1/20 0.35
DRD1 P21728 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20767080 0.82 BCHE (0.50) BCHEACHEBACE1PABPC1KDM4E
SCHEMBL16795184 0.81 BCHE (0.52) BCHEACHEBACE1PABPC1CARM1
SCHEMBL27709142 0.78 BCHE (0.49) BCHEACHEBACE1PABPC1KDM4E
SCHEMBL29546328 0.72 BCHE (0.64) BCHEACHEBACE1KDM4EALDH1A1
SCHEMBL20766753 0.72 BCHE (0.64) BCHEACHEBACE1KDM4EALDH1A1
SCHEMBL12074561 0.71 ACHE (0.50) BCHEACHEBACE1KDM4EALDH1A1
SCHEMBL20780551 0.71 BCHE (0.50) BCHEACHEBACE1KDM4EALDH1A1
SCHEMBL12074147 0.71 BCHE (0.50) BCHEACHEBACE1KDM4EALDH1A1
SCHEMBL20766411 0.71 MEN1 (0.46) BCHEACHEBACE1KDM4EALDH1A1
SCHEMBL30523669 0.71 MEN1 (0.46) BCHEACHEBACE1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015086693-A1 PYRAZOLOPYRIMIDIN-2-YL DERIVATIVES AS JAK INHIBITORS ALMIRALL, S.A. (ES) 2015-06-18 WO disclosed